Because in humans APOE alleles have a major impact on aging-associated diseases, particularly cardiovascular disease, type 2 diabetes and late-onset AD we focused on the effect of the Apoe variants we identified in the degu. This evidence concerns the gene APOE and type 2 diabetes mellitus.